# Phase I Study of GSK2982772 in Japanese Healthy Male Participants

> **NCT03590613** · PHASE1 · COMPLETED · sponsor: **GlaxoSmithKline** · enrollment: 13 (actual)

## Conditions studied

- Autoimmune Diseases

## Interventions

- **DRUG:** GSK2982772
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT03590613
- **Lead sponsor:** GlaxoSmithKline
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2018-07-19
- **Primary completion:** 2018-09-21
- **Final completion:** 2018-09-26
- **Target enrollment:** 13 (ACTUAL)
- **Last updated:** 2023-10-04


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT03590613

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT03590613, "Phase I Study of GSK2982772 in Japanese Healthy Male Participants". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT03590613. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*